Charles Sang

SENIOR VICE PRESIDENT, ADAPTIVE DIAGNOSTICS

Mr. Sang oversees the global product strategy and management of our Diagnostics business. He was most recently the Vice President of Global Diagnostics for Nanostring Technologies, Inc. and led their North American and Global commercial efforts for a new product class of decentralized genomic assays in solid and liquid tumors. Mr. Sang has more than 20 years of Hematology/Oncology expertise, including the global launch of products in highly specialized markets while ensuring their reimbursement. He has also held commercial leadership positions at Seattle Genetics and Enzon Pharmaceuticals. Mr. Sang obtained his Master’s degree from New Mexico State University.

back_to_top